Sanofi Joins Drugmakers' Bid to Treat Patients With Software

Sanofi is joining other big pharmaceutical companies in expanding beyond pills and injections into a new frontier of tech-based treatments that doctors can prescribe.

Working with partner Happify Health, the French drugmaker is studying a potential digital therapy for patients with depression and multiple sclerosis.